•
RD
RDHL
Redhill Biopharma Ltd.
polygon--
Price Chart
Market Cap
6.87M
Volume
5.69K
52W High
$6.80
52W Low
$0.91
Open
$1.31
Prev Close
$1.35
Day Range
1.30 - 1.34
About Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Latest News
RedHill Biopharma Receives Nasdaq Staff Determination Notification
Benzinga•Oct 22
Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings
Benzinga•Jan 25
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga•Jan 25
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
Benzinga•Jan 25
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Jan 24
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 24
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Dec 20
Bill Gross says beaten-down mortgage plays may thrive — and offer huge yields
MarketWatch•Dec 1